HCPCS Level IIdrugActive
J0638
Canakinumab injection
BETOS: O1E
Effective: 2011-01-01
Referenced in 1 policies
Description
Injection, canakinumab, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Ilaris
Manufacturer
Novartis Pharmaceuticals Corporation
HCPCS Dosage
1 MG
Billing Units
150.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.